Cargando…

Temporal, age, and geographical variation in vaccine efficacy against infection by the Delta and Omicron variants in the community in France, December 2021 to March 2022

OBJECTIVES: We aimed to quantify how the vaccine efficacy of BNT162b2, messenger RNA-1273, AD26.COV2-S, and ChAdOx1 nCoV-19 against detected infection by the SARS-CoV-2 Delta and Omicron variants varied by time since the last dose, vaccine scheme, age, and geographic areas. METHODS: We analyzed 3,26...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanquart, François, Abad, Clémence, Ambroise, Joevin, Bernard, Mathieu, Débarre, Florence, Giannoli, Jean-Marc, Rey, Thomas, Vieillefond, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176971/ https://www.ncbi.nlm.nih.gov/pubmed/37182550 http://dx.doi.org/10.1016/j.ijid.2023.04.410

Ejemplares similares

Characterisation of vaccine breakthrough infections of SARS-CoV-2 Delta and Alpha variants and within-host viral load dynamics in the community, France, June to July 2021
por: Blanquart, François, et al.
Publicado: (2021)

Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022
por: Suarez Castillo, Milena, et al.
Publicado: (2022)

Avian influenza overview December 2021 – March 2022
por: Adlhoch, Cornelia, et al.
Publicado: (2022)

Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022
por: Bastard, Jonathan, et al.
Publicado: (2022)

Investigation of vaccine breakthrough infections by vaccination scheme during the Delta variant wave in France
por: Bal, Antonin, et al.
Publicado: (2022)

Avian influenza overview December 2022 – March 2023
por: Adlhoch, Cornelia, et al.
Publicado: (2023)

Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021–January 2022: A retrospective, population-based, matched cohort study
por: Auvigne, Vincent, et al.
Publicado: (2022)

Martin Ravallion: 19 March 1952 – 24 December 2022
por: Cowell, Frank A.
Publicado: (2023)

Reactive surveillance of suicides during the COVID-19 pandemic in France, 2020 to March 2022
por: Fouillet, Anne, et al.
Publicado: (2023)

Outbreaks of SARS-CoV-2 Infections in Nursing Homes during Periods of Delta and Omicron Predominance, United States, July 2021–March 2022
por: Wilson, W. Wyatt, et al.
Publicado: (2023)

A third vaccine dose equalises the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens, Lyon, France, December 2021 to March 2022
por: Guibert, Nicolas, et al.
Publicado: (2023)

First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022
por: Maisa, A., et al.
Publicado: (2022)

Reactive surveillance of suicides during the COVID-19 epidemic in France, 2020- March 2022: Anne Fouillet
por: Fouillet, A, et al.
Publicado: (2022)

Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022
por: Stefanelli, Paola, et al.
Publicado: (2022)

Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19–December 31, 2021
por: Kremer, Cécile, et al.
Publicado: (2022)

Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022
por: Piralla, Antonio, et al.
Publicado: (2023)

Functional immunity against SARS-CoV-2 in the general population after a booster campaign and the Delta and Omicron waves, Switzerland, March 2022
por: Amati, Rebecca, et al.
Publicado: (2022)

Factors favouring the evolution of multidrug resistance in bacteria
por: Jacopin, Eliott, et al.
Publicado: (2020)

The stochastic dynamics of early epidemics: probability of establishment, initial growth rate, and infection cluster size at first detection
por: Czuppon, Peter, et al.
Publicado: (2021)

A stochastic analysis of the interplay between antibiotic dose, mode of action, and bacterial competition in the evolution of antibiotic resistance
por: Czuppon, Peter, et al.
Publicado: (2023)

January 2022-December 2022
Publicado: (2022)

Projection of healthcare demand in Germany and Switzerland urged by Omicron wave (January–March 2022)
por: Gorji, Hossein, et al.
Publicado: (2023)

Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2022)

Autochthonous dengue in mainland France, 2022: geographical extension and incidence increase
por: Cochet, Amandine, et al.
Publicado: (2022)

Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)
por: Petrone, Daniele, et al.
Publicado: (2023)

COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants – surveillance results from southern Sweden, December 2021 to March 2022
por: Björk, Jonas, et al.
Publicado: (2022)

Effectiveness of MRNA booster vaccine among healthcare workers in New York City during the Omicron surge, December 2021 to January 2022
por: Robilotti, Elizabeth V., et al.
Publicado: (2022)

Estimating the impact of vaccination on reducing COVID-19 burden in the United States: December 2020 to March 2022
por: Sah, Pratha, et al.
Publicado: (2022)

December 2022 obituaries
Publicado: (2022)

Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
por: Braeye, Toon, et al.
Publicado: (2023)

Antibiotic-Resistant Bacteria in Drinking Water from the Greater Accra Region, Ghana: A Cross-Sectional Study, December 2021–March 2022
por: Ahmed, Hawa, et al.
Publicado: (2022)

Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants
por: Blanquart, François, et al.
Publicado: (2022)

Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020
por: Holden, Tobias M., et al.
Publicado: (2021)

Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020
por: Holden, Tobias M, et al.
Publicado: (2021)

Genomic Variability of SARS-CoV-2 Omicron Variant Circulating in the Russian Federation during Early December 2021 and Late January 2022
por: Chernyaeva, Ekaterina N., et al.
Publicado: (2022)

Comparison of Omicron and Delta Variant Infection COVID-19 Cases — Guangdong Province, China, 2022
por: Hu, Ting, et al.
Publicado: (2022)

Can variants, reinfection, symptoms and test types affect COVID-19 diagnostic performance? A large-scale retrospective study of AG-RDTs during circulation of Delta and Omicron variants, Czechia, December 2021 to February 2022
por: Kliegr, Tomáš, et al.
Publicado: (2023)

Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year in Southeastern France
por: Giraud-Gatineau, Audrey, et al.
Publicado: (2020)

The Infection of Healthcare Workers and the Reinfection of Patients by Omicron Variant — Jiangsu Province, China, December 2022 to January 2023
por: Zhang, Chuanmeng, et al.
Publicado: (2023)

Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021
por: Backer, Jantien A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aft3rs1seud0s01et3ksgbj5jt